Baxter International Inc. (NYSE:BAX) Strong Growth Forecast

By HEFFX Australia on July 6, 2020   Headline News, Health, Heffx Insights, Investments, Shayne Heffernan, Shayne Heffernan, Stocks, Todays Trade Ideas, US Stocks  

$BAX #USA #NYSE #Stocks #Baxter #Medical #Covid #ShayneHeffernan BaxterTicker: NYSE:BAXPrice: $87.21Recommendation: BuyTarget Price: $97.47Long-Term Growth: 9.67% Business Summary Baxter International Inc., through its subsidiaries, provides renal and hospital products. The Company operates through two segments: Hospital Products and Renal. Its Hospital Products business manufactures sterile intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution […]